Biogen strongly believes that collaboration with healthcare professionals is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.

As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations), Biogen is proud to endorse and uphold the EFPIA Disclosure Code. In line with the code, Biogen has been collecting all payments and contributions made to Healthcare Professionals and Organizations since January 2015.

Biogen International GmbH is committed to work with patient organizations and supporting their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies with a focus on serious neurological, autoimmune and rare diseases.

In 2016, Biogen International GmbH provided funding to the patient organizations listed below in support of several important projects.

Patient organization Project Amount of support
Alzheimer’s Disease International Support projects for  related to raising awareness of Alzheimer's, supporting World AD Month 2016 and Alzheimer University training course
55.000 USD
EFNA - European Federation of Neurological Associations Support for European Parliament MEP Interest Group on Brain, Mind and Pain 10.000 EUR
EMSP - European MS Platform Support for patient educational activities and projects; EUReMS; Paediatric MS; Believe and Achieve; Capacity training; MS Barometer; MS Nurse Pro; Comprehensive Mapping; European Parliament Event; Travel bursary ECTRIMS 2017 and Ready for work 308.850 EUR
EURORDIS Biogen is a member of the EURORDIS Round Table of Companies
10.000 EUR
MSIF - MS International Federation Support for World MS Day 2015, Project Principles Quality of life and  stronger capacity building programs for MS organizations globally – focusing on the Middle East and Latin America 120.000 GBP